A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2004
12/23/2004	DE10325672A1 Pharmazeutisches Präparat zur Behandlung von parasitären Tropenkrankheiten A pharmaceutical preparation for the treatment of parasitic tropical diseases
12/23/2004	DE10324997A1 Mrp8/Mrp14 Inhibitoren und ihre Verwendung zur Prävention und/oder Behandlung von hypertrophen Narben und Keloiden MRP8 / MRP14 inhibitors and their use for the prevention and / or treatment of hypertrophic scars and keloids
12/23/2004	DE10308355A1 Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel Aryl-cycloalkyl substituted alkane acid derivatives, processes for their preparation and their use as medicaments
12/23/2004	DE10103860B4 Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung Transdermal therapeutic system for the administration of carboxyl-containing, non-steroidal anti-inflammatory agents, and to processes for its preparation
12/23/2004	CA2849228A1 Process for the manufacture of stable shaped particles consisting of estradiol and cholesterol
12/23/2004	CA2756058A1 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
12/23/2004	CA2727748A1 Inosine derivatives and production methods therefor
12/23/2004	CA2569585A1 Compositions for oral administration of campothecin and its analogs
12/23/2004	CA2531829A1 Synergistic combinations including n-acylated 4-hydroxyphenylamine derivatives and caffeine
12/23/2004	CA2531406A1 Aporphine and oxoaporphine and the medical use thereof
12/23/2004	CA2530634A1 Methods of treating obesity and related disorders using tellurium and selenium compounds
12/23/2004	CA2529806A1 Diphenylurea derivatives and their use as chloride channel blockers
12/23/2004	CA2529729A1 New imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
12/23/2004	CA2529486A1 Method for selective targeting of apoptotic cells and small molecule ligands used thereof
12/23/2004	CA2529478A1 Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases
12/23/2004	CA2529225A1 Pharmaceutical composition and method for alleviating side effects of estrogen replacement therapy
12/23/2004	CA2529102A1 Pharmaceutical formulations comprising amoxicillin and clavulanate
12/23/2004	CA2529090A1 2-aminopyrimidine derivatives as raf kinase inhibitors
12/23/2004	CA2529068A1 Pyrimidine derivatives as cannabinoid receptor ligands
12/23/2004	CA2528993A1 Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
12/23/2004	CA2528932A1 Pharmaceutically useful salts of carboxylic acid derivates
12/23/2004	CA2528929A1 Cyclic tertiary amine compound
12/23/2004	CA2528905A1 Neurocyte protective agent
12/23/2004	CA2528644A1 Novel piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl lactams
12/23/2004	CA2528552A1 Pharmaceutical compositions comprising active vitamin d compounds
12/23/2004	CA2528547A1 Saururus cernuus compounds that inhibit cellular responses to hypoxia
12/23/2004	CA2528545A1 Process for the manufacture of stable shaped particles consisting of estradiol and cholesterol
12/23/2004	CA2528479A1 Formoterol and ciclesonide combination
12/23/2004	CA2528433A1 Thiadiazoline derivative
12/23/2004	CA2528409A1 Use of 2-amino-1-3-propanediol derivatives for the manufacture of a medicament for the treatment of various types of pain
12/23/2004	CA2528402A1 Sphingoid polyalkylamine conjugates for vaccination
12/23/2004	CA2528395A1 Treatment for alzheimer's disease and related conditions
12/23/2004	CA2528382A1 3-(guanidinocarbonyl)heterocycle derivatives, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions including them
12/23/2004	CA2528378A1 Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents
12/23/2004	CA2528367A1 A1 adenosine receptor antagonists
12/23/2004	CA2528365A1 Asenapine for the treatment of schizophrenia in a patient with overweight or predisposition for overweight
12/23/2004	CA2528360A1 Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine
12/23/2004	CA2528359A1 Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
12/23/2004	CA2528321A1 Tetrahydrocarbazole derivatives and their pharmaceutical use
12/23/2004	CA2528231A1 New benzamides as ppar.gamma. modulators
12/23/2004	CA2528090A1 Porphyrins and metalloporphyrins for inhibiting heme iron uptake
12/23/2004	CA2528003A1 Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
12/23/2004	CA2527977A1 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator
12/23/2004	CA2527906A1 Acylated imidazo[2,1-b]-1,3,4,-thiadiazole-2-sulfonamides and uses thereof
12/23/2004	CA2527903A1 Imidazo[2,1-b]-1,3,4-thiadiazole sulfoxides and sulfones
12/23/2004	CA2527869A1 Method for the treatment of malignancies
12/23/2004	CA2527856A1 Substituted 1, 4-di-piperidin-4-yl-piperazine derivative combined with an opioid analgesic and their use for the treatment of pain and side-effects associated with opioid-based treatments
12/23/2004	CA2527851A1 Hepatitis c virus inhibitors
12/23/2004	CA2527832A1 1.3.4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives
12/23/2004	CA2527773A1 Cycloalkanepyrrolopyridines as dp receptor antagonists
12/23/2004	CA2527608A1 Pharmaceutically useful salts of carboxylic acid derivates
12/23/2004	CA2527591A1 Thiophenepyrimidinones as 17-beta-hydroxysteroid dehydrogenase inhibitors
12/23/2004	CA2527586A1 Pyridine n-oxides as antiviral agents
12/23/2004	CA2527368A1 Pharmaceutical composition
12/23/2004	CA2527246A1 Aniline derivatives
12/23/2004	CA2527236A1 Thiotungstate analogues and uses thereof
12/23/2004	CA2527033A1 2-substitued 5,6-diaryl-pyrazine derivatives as cb1 modulators
12/23/2004	CA2526872A1 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
12/23/2004	CA2526770A1 Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/23/2004	CA2526567A1 Oil emulsion for postnatal hormone substitution
12/23/2004	CA2526518A1 1-aryl-4-(aryloxycarbonyl)-piperazine derivatives for use as inhibitors of hormone sensitive lipase
12/23/2004	CA2526387A1 Benzamide derivative or salt thereof
12/23/2004	CA2526285A1 Inhibitors of p38 and methods of using the same
12/23/2004	CA2526217A1 Heteroaryl-fused pyrimidinyl compounds as anticancer agents
12/23/2004	CA2526209A1 Cyclic hydroxylamine as psychoactive compounds
12/23/2004	CA2526204A1 Pyridinyl carbamates as hormone-sensitive lipase inhibitors
12/23/2004	CA2526101A1 Implantable polymeric device for sustained release of nalmefene
12/23/2004	CA2526048A1 Bicyclic indolyl derivatives and methods of their use as serotonergic agents
12/23/2004	CA2526041A1 Anthranylamide pyridones that inhibit vegfr-2 and vegfr-3
12/23/2004	CA2525966A1 Novel immunomodulating peptide
12/23/2004	CA2525917A1 Compositions and methods including a recombinant human mab that promotes cns remyelination
12/23/2004	CA2525784A1 Proteoglycan degrading mutants for treatment of cns
12/23/2004	CA2525782A1 Degradation of glycosaminoglycans in extracellular matrix to treat cns injury
12/23/2004	CA2525517A1 Use of prion conversion modulating agents
12/23/2004	CA2525207A1 Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase
12/23/2004	CA2524639A1 Compositions and methods for reducing scar tissue formation
12/23/2004	CA2523858A1 Heterocyclic compounds and uses thereof
12/23/2004	CA2523808A1 Pyrrole compounds and uses thereof
12/23/2004	CA2520148A1 Compositions and methods for treating coronavirus infection and sars
12/23/2004	CA2519875A1 Method of tumor regression with vegf inhibitors
12/23/2004	CA2494704A1 Radioactively labelled amino acid analogues, their preparation and use
12/23/2004	CA2433101A1 Method of treatment of a female suffering from androgen insufficiency
12/22/2004	EP1489189A1 Diagnostics and remedies for malignant brain tumor
12/22/2004	EP1489187A1 Osteoclast differentiation inhibitors
12/22/2004	EP1489186A1 Angiogenesis inhibitors
12/22/2004	EP1489185A1 Methods and compositions for use in splicesome mediated rna trans-splicing
12/22/2004	EP1489171A1 Functional molecule and process for producing the same
12/22/2004	EP1489170A1 Transporter selectively transporting sulfate conjugate and its gene
12/22/2004	EP1489101A1 Novel branched sialo-sugar molecules and antiviral agents using the same
12/22/2004	EP1489091A1 Process for producing triterpene derivative
12/22/2004	EP1489089A1 Crystals of glucopyranosyloxybenzyl benzene derivative
12/22/2004	EP1489088A1 Novel alpha-amino-n-(diaminophosphinyl)lactam derivative
12/22/2004	EP1489084A1 Broad-spectrum cephem compounds
12/22/2004	EP1489082A1 Intermediate compounds
12/22/2004	EP1489081A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient
12/22/2004	EP1489077A1 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
12/22/2004	EP1488812A1 Liquid matrix undergoing phase transfer in vivo and liquid oral preparations
12/22/2004	EP1488811A1 Tablets quickly disintegrating in oral cavity
12/22/2004	EP1488810A1 Percutaneous absorption promoters and compositions for treating athlete's foot
12/22/2004	EP1488809A1 Pharmaceutical combination containing a 4-quinazolineamine and another anti-neoplastic agent for the treatment of cancer

1 ... 4850 4851 4852 4853 4854 4855 4856 4857 4858 4859 4860 4861 4862 4863 4864 4865 4866 4867 4868 4869 4870 ... 7860